The Seattle-based Institute for Systems Biology and Mountain View, CA-based Complete Genomics said today they are planning to gather full human genome sequences from 100 individuals to study Huntington’s disease. The experiment, the largest complete human genome disease association study ever conducted, will examine samples from patients with Huntington’s, family members, and matched controls to look for genomic differences linked to how the disease presents itself and progresses. Complete Genomics, which we profiled in August, is best known for its effort to sequence entire human genomes for $5,000 apiece, far cheaper than is currently possible with other technologies.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
